Kenneth John Colley MD PhD (He/Him)
Clinical Pharmacology
Exec Medical Director | Clinical Development | Translational and Integrative Medicine | Biotech and Wellness Entrepreneur
Join to View Full Profile
27 W Anapamu StSte 448Santa Barbara, CA 93101
Dr. Colley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- linkedin.com/in/drkencolley/
Education & Training
Johns Hopkins UniversityInternship, Internal Medicine, 1996 - 1997
Georgetown University School of MedicineClass of 1996
Certifications & Licensure
CA State Medical License 1999 - 2026
MD State Medical License 1997 - 1998
Publications & Presentations
PubMed
- 11 citationsPhase I study in healthy participants to evaluate safety, tolerability, and pharmacokinetics of inhaled nezulcitinib, a potential treatment for COVID-19.Nathan D. Pfeifer, Arthur Lo, David L. Bourdet, Kenneth Colley, Dave Singh
Clinical and Translational Science. 2021-08-31 - 1 citationsSafety, Pharmacokinetics, and Pharmacodynamics of TD-0714, a Novel Potent Neprilysin Inhibitor in Healthy Adult and Elderly Subjects.Jitendra Kanodia, Arthur Lo, R. Michael Baldwin, Ken Colley, Kefei Zhou
Clinical and Translational Science. 2020-11-01 - 36 citationsLipoprotein associated phospholipase A 2 : role in atherosclerosis and utility as a biomarker for cardiovascular riskKenneth J. Colley, Robert L. Wolfert, Michael E. Cobble
The EPMA Journal. 2011-03-10
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
